These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32352682)

  • 1. The Association Between Cholecystectomy, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
    Latenstein CSS; Alferink LJM; Darwish Murad S; Drenth JPH; van Laarhoven CJHM; de Reuver PR
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00170. PubMed ID: 32352682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan.
    Shen HC; Zhao ZH; Hu YC; Chen YF; Tung TH
    Clin Interv Aging; 2014; 9():501-8. PubMed ID: 24741297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.
    Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
    World J Gastroenterol; 2015 May; 21(20):6287-95. PubMed ID: 26034364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study.
    Lu Y; Hu L; Song J; Wan J; Chen H; Yin J
    BMC Endocr Disord; 2021 Nov; 21(1):231. PubMed ID: 34794397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey.
    Yue W; Sun X; Du T
    BMC Endocr Disord; 2019 Sep; 19(1):95. PubMed ID: 31477078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    van Kleef LA; Hofman A; Voortman T; de Knegt RJ
    Am J Gastroenterol; 2022 Feb; 117(2):311-318. PubMed ID: 34904966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.
    van Kleef LA; Ayada I; Alferink LJM; Pan Q; de Knegt RJ
    Hepatology; 2022 Feb; 75(2):419-429. PubMed ID: 34453359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation of risk factors between metabolic syndrome and nonalcoholic fatty liver disease in children and adolescents].
    Smolka V; Ehrmann J; Tkachyk O; Zápalka M
    Cas Lek Cesk; 2014; 153(2):91-7. PubMed ID: 24797780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
    Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
    Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease.
    Lyu J; Lin Q; Fang Z; Xu Z; Liu Z
    Front Endocrinol (Lausanne); 2022; 13():1032557. PubMed ID: 36506064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease: Evolving paradigms.
    Lonardo A; Nascimbeni F; Maurantonio M; Marrazzo A; Rinaldi L; Adinolfi LE
    World J Gastroenterol; 2017 Sep; 23(36):6571-6592. PubMed ID: 29085206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic.
    Dvorak K; Hainer R; Petrtyl J; Zeman M; Vareka T; Zak A; Sroubkova R; Svestka T; Vitek L; Bruha R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):442-8. PubMed ID: 25004910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).
    Golabi P; Otgonsuren M; de Avila L; Sayiner M; Rafiq N; Younossi ZM
    Medicine (Baltimore); 2018 Mar; 97(13):e0214. PubMed ID: 29595666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome.
    Mustapic S; Ziga S; Matic V; Bokun T; Radic B; Lucijanic M; Marusic S; Babic Z; Grgurevic I
    Can J Gastroenterol Hepatol; 2018; 2018():8490242. PubMed ID: 30211140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.